(Q45745547)

15 December 2017

title

Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease (English)

1 reference

15 December 2017

non-alcoholic fatty liver

0 references

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

6

1 reference

15 December 2017

Adil Mardinoglu

object named as

Adil Mardinoglu

1

0 references

Mathias Uhlén

5

object named as

Mathias Uhlen

1 reference

15 December 2017

author name string

Rasmus Agren

2

1 reference

15 December 2017

Caroline Kampf

3

1 reference

15 December 2017

Anna Asplund

4

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

15 December 2017

published in

Nature Communications

1 reference

15 December 2017

volume

5

1 reference

15 December 2017

page(s)

3083

1 reference

15 December 2017

HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

A simple index of lipid overaccumulation is a good marker of liver steatosis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Inborn errors of metabolism: the flux from Mendelian to complex diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

The emerging paradigm of network medicine in the study of human disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Systems medicine and metabolic modelling

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Understanding the interactions between bacteria in the human gut through metabolic modeling

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Novel insights into obesity and diabetes through genome-scale metabolic modeling

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Genome-scale modeling of human metabolism - a systems biology approach

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Systems biology of lipid metabolism: from yeast to human

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Global reconstruction of the human metabolic network based on genomic and bibliomic data

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

The Edinburgh human metabolic network reconstruction and its functional analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Compartmentalization of the Edinburgh Human Metabolic Network

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

A community-driven global reconstruction of human metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Integration of clinical data with a genome-scale metabolic model of the human adipocyte

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Interplay between lipids and branched-chain amino acids in development of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Towards a knowledge-based Human Protein Atlas

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Computational reconstruction of tissue‐specific metabolic models: application to human liver metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Metabolic flux analysis of cultured hepatocytes exposed to plasma

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Non-alcoholic fatty liver disease and the metabolic syndrome: an update

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Targeted metabolomics for biomarker discovery.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Uncovering transcriptional regulation of metabolism by using metabolic network topology

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Gene expression in human NAFLD.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Glycosaminoglycans: key players in cancer cell biology and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Lipid droplets finally get a little R-E-S-P-E-C-T.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Plasma metabolomic profile in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Serine is a natural ligand and allosteric activator of pyruvate kinase M2

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Context-specific metabolic networks are consistent with experiments

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Network-based prediction of human tissue-specific metabolism

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Long-term adaptation of weanling rats to high dietary levels of methionine and serine

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

The reactions of the phosphorylated pathway of L-serine biosynthesis: thermodynamic relationships in rabbit liver in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

KEGG for representation and analysis of molecular networks involving diseases and drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Reactome: a database of reactions, pathways and biological processes

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Applications of mass spectrometry to lipids and membranes

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Computational prediction of human metabolic pathways from the complete human genome

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Ongoing and future developments at the Universal Protein Resource

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

LMPD: LIPID MAPS proteome database

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4083

7 January 2021

Identifiers

DOI

10.1038/NCOMMS4083

1 reference

15 December 2017

Dimensions Publication ID

ADS bibcode

2014NatCo...5.3083M

0 references

1045416438

0 references

1 reference

15 December 2017